Fiche de révision : Pathology of Tumors and Glomerulonephritis

📋 Course Outline

1. Glomerulonephritis Types
2. Tumor Markers
3. Lymphoma Subtypes
4. Breast Cancer Features
5. Ovarian Tumors
6. Renal Pathologies
7. Neoplastic Lesions
8. Histological Features
9. Genetic Abnormalities
10. Tumor Staging

📖 1. Glomerulonephritis Types

🔑 Key Concepts & Definitions

• Membranous glomerulonephritis (characterized by electron-dense thickening of the glomerular basement membrane due to complement deposition). This thickening results from immune complex deposits on the subepithelial side of the basement membrane, leading to a "spike and dome" appearance (formation of basement membrane spikes in membranous glomerulonephritis).
• Membranoproliferative glomerulonephritis (MPGN) Types I and II: Distinct forms of immune complex-mediated glomerulonephritis. Type I involves subendothelial immune deposits, while Type II (also called dense deposit disease) features intramembranous dense deposits within the basement membrane, often associated with complement activation (see authors for detailed classification).
• IgA nephropathy (also known as Berger's disease): Features mesangial IgA deposits seen on immunofluorescence, with complement activation playing a role. It is the most common form of primary glomerulonephritis worldwide and involves immune complex deposition predominantly in the mesangium, leading to mesangial proliferation.
• Primary vs secondary glomerulopathies: Primary glomerulopathies are intrinsic to the kidney (e.g., membranous glomerulonephritis, IgA nephropathy), whereas secondary forms are caused by systemic diseases or external factors (e.g., amyloidosis, Goodpasture syndrome).
• Formation of basement membrane spikes: In membranous glomerulonephritis, immune complexes deposit on the outer basement membrane, leading to the formation of spikes—projections of basement membrane material seen histologically, characteristic of this disease.

📝 Essential Points

• The electron-dense thickening of the basement membrane in membranous glomerulonephritis is due to complement and immune complex deposits, which activate the complement cascade, causing damage and thickening.
• Membranoproliferative glomerulonephritis is classified into Type I (subendothelial deposits) and Type II (dense intramembranous deposits), with Type II associated with complement pathway dysregulation and dense deposit disease.
• IgA nephropathy involves mesangial IgA deposits with complement activation, often presenting with episodic hematuria following mucosal infections.
• Primary glomerulopathies are idiopathic, while secondary glomerulopathies are linked to systemic conditions such as amyloidosis (deposits of amyloid protein) and Goodpasture syndrome (autoantibodies against glomerular basement membrane).
• The spikes in membranous glomerulonephritis are formed by new basement membrane material deposited between immune complexes, creating characteristic histological features.

💡 Key Takeaway

Membranous glomerulonephritis is marked by immune complex deposits causing basement membrane thickening and spike formation, while MPGN types I and II differ in deposit location and complement involvement; IgA nephropathy features mesangial IgA deposits with complement activation, and understanding primary versus secondary glomerulopathies aids in diagnosis and management.

📖 2. Tumor Markers

🔑 Key Concepts & Definitions

• Bcl-2 Overexpression in Follicular Lymphoma (t(10;18)): An anti-apoptotic protein overexpressed due to the t(10;18)(q24;q21) translocation, characteristic of follicular lymphoma, which promotes tumor cell survival (Author (date)).
• Immunophenotype of Sezary Syndrome Cells: Neoplastic T-cells typically express CD2+, CD3+, CD4+, and lack CD7- (Author (date)), aiding in diagnosis and differentiation from other T-cell lymphomas.
• Role of Oncogene Activation and Receptor Expression in Breast Carcinoma: Activation of oncogenes (e.g., HER2/neu) and receptor status (estrogen and progesterone receptors) serve as prognostic factors, influencing treatment response (Author (date)).
• HPV Types and Etiologic Role in Epithelial Lesions: Certain HPV types, such as HPV-12, are etiologically linked to specific lesions like verruca, with distinct pathogenic mechanisms (Author (date)).
• ALK Gene Fusion in Anaplastic Large Cell Lymphoma (t(2;5)(p23;q35)): Fusion of ALK gene with NPM1 resulting from t(2;5)(p23;q35) translocation leads to constitutive kinase activity, characteristic of ALCL, and has prognostic implications (Author (date)).

📝 Essential Points

• Tumor markers like bcl-2 overexpression are crucial in diagnosing follicular lymphoma, especially with the presence of t(10;18), which causes the overproduction of the anti-apoptotic protein, contributing to tumor cell survival (Author (date)).
• The immunophenotype of Sezary syndrome cells (CD2+, CD3+, CD4+, CD7-) helps distinguish it from other cutaneous T-cell lymphomas and guides targeted therapies (Author (date)).
• In breast carcinoma, oncogene activation (e.g., HER2/neu) and receptor expression (ER, PR) are significant prognostic factors, influencing both prognosis and therapeutic options (Author (date)).
• The etiologic role of HPV types varies; HPV-12 is associated with verruca, while other types are linked to different epithelial lesions, emphasizing the importance of HPV typing in diagnosis and prevention (Author (date)).
• The ALK gene fusion resulting from t(2;5)(p23;q35) translocation is pathognomonic for ALCL, influencing prognosis and response to targeted therapies like ALK inhibitors (Author (date)).

💡 Key Takeaway

Tumor markers such as genetic translocations, protein overexpression, and receptor status are vital for diagnosis, prognosis, and targeted therapy in lymphoma and carcinoma, with specific markers like bcl-2, ALK fusion, and HPV types playing crucial roles.

📖 3. Lymphoma Subtypes

🔑 Key Concepts & Definitions

• Mantle Cell Lymphoma Immunophenotype: A subtype of B-cell lymphoma characterized by expression of CD20+, CD5+, and cyclin D1+ (see genetic abnormalities). Cyclin D1 overexpression results from the t(11;14)(q13;q32) translocation, which is diagnostic for this lymphoma (source content).

• Anaplastic Large Cell Lymphoma (ALCL) Translocation t(2;5): A T-cell lymphoma distinguished by the chromosomal translocation t(2;5)(p23;q35), leading to ALK gene fusion. This genetic abnormality is specific for ALCL and is associated with a better prognosis (source content).

• Features of Lymph Node Biopsy with Hyperplastic Germinal Centers and Granulomas: Reactive lymph nodes may show hyperplastic germinal centers, indicative of immune response, and granulomas, which are organized collections of macrophages, often due to infections or inflammatory conditions. These features help differentiate reactive from neoplastic processes (source content).

• Classification of Lymphoma by Immunohistochemistry and Genetic Abnormalities: Lymphomas are classified based on immunophenotypic markers (e.g., CD20, CD3, ALK) and genetic translocations or mutations (e.g., t(11;14) in mantle cell lymphoma, t(2;5) in ALCL). This classification guides diagnosis, prognosis, and therapy (source content).

📝 Essential Points

• Mantle cell lymphoma expresses CD20+, CD5+, and cyclin D1+ due to the t(11;14)(q13;q32) translocation, which results in cyclin D1 overexpression, a hallmark for diagnosis (source content).

• Anaplastic large cell lymphoma often features the t(2;5)(p23;q35) translocation, leading to ALK fusion protein expression, which is associated with a favorable prognosis and responsiveness to targeted therapy (source content).

• Reactive lymph nodes can display hyperplastic germinal centers, reflecting immune activation, and granulomas, which are indicative of infectious or inflammatory etiologies, not lymphoma (source content).

• Accurate classification of lymphomas involves immunohistochemistry to determine cell lineage and genetic testing for characteristic translocations or mutations, enabling precise diagnosis and tailored treatment (source content).

💡 Key Takeaway

Lymphoma subtypes are distinguished by specific immunophenotypic profiles and genetic abnormalities, which are crucial for accurate diagnosis, prognosis, and targeted therapy.

📖 4. Breast Cancer Features

🔑 Key Concepts & Definitions

• Histological grading percentages in breast carcinoma (G1, G2, G3 distribution):
  The classification of breast carcinoma based on the percentage of tumor cells showing differentiation, with G1 (well-differentiated) comprising approximately 40-60%, G2 (moderately differentiated) around 35-50%, and G3 (poorly differentiated) about 10-25%, reflecting tumor aggressiveness and prognosis (source data).

• Macroscopic features of papillary carcinoma of the breast:
  Typically presents as a solid, cystic, and hemorrhagic mass, often with a papillary architecture visible upon gross examination, aiding in diagnosis and surgical planning (source data).

• Prognostic importance of mitotic count and differentiation grade in breast cancer:
  Higher mitotic counts and poorer differentiation (G3) are associated with more aggressive tumors and worse prognosis, guiding treatment decisions and predicting outcomes (source data).

• Common sites and clinical features of breast cancer nodules:
  Usually occur in the upper outer quadrant of the breast, presenting as firm, irregular, and non-tender nodules that may be fixed to surrounding tissues, with potential regional lymph node involvement (source data).

• BRCA1 and BRCA2 mutations as risk factors for breast and ovarian cancer:
  Germline mutations in these tumor suppressor genes significantly increase lifetime risk for breast and ovarian cancers, with BRCA1 mutations linked more to triple-negative breast cancers and ovarian carcinomas, as identified in familial cancer syndromes (source data).

📝 Essential Points

• The distribution of histological grades (G1, G2, G3) in breast carcinoma reflects tumor differentiation and correlates with prognosis; G1 tumors are well-differentiated, G2 moderately differentiated, and G3 poorly differentiated, with G3 tumors showing higher mitotic activity and aggressive behavior (source data).

• Macroscopically, papillary carcinoma of the breast appears as a solid, cystic, and hemorrhagic mass, often with a papillary surface, which can be distinguished from other tumor types during gross examination (source data).

• The mitotic count and differentiation grade are critical prognostic factors; increased mitoses and low differentiation (G3) are associated with poorer outcomes, influencing therapeutic strategies (source data).

• Breast cancer nodules most frequently occur in the upper outer quadrant, with clinical features including firmness, irregular shape, and potential fixation to skin or chest wall, often accompanied by axillary lymphadenopathy (source data).

• BRCA1 and BRCA2 mutations are inherited genetic alterations that markedly elevate the risk for breast and ovarian cancers; genetic testing is recommended for high-risk individuals, impacting screening and preventive measures (source data).

💡 Key Takeaway

Histological grading, macroscopic features, and genetic risk factors like BRCA mutations are essential for understanding breast cancer behavior, prognosis, and management strategies.

📖 5. Ovarian Tumors

🔑 Key Concepts & Definitions

• Dysgerminoma: A malignant germ cell tumor of the ovary, histologically similar to seminoma of the testis, characterized by large, uniform cells with clear cytoplasm and prominent nuclei, often associated with elevated serum LDH levels. (Source content)

• Embryonal Carcinoma: A highly malignant germ cell tumor composed of primitive, undifferentiated cells resembling embryonic tissue, with aggressive behavior and potential to metastasize early. (Source content)

• Teratocarcinoma: A malignant germ cell tumor that contains both teratomatous (differentiated tissues from multiple germ layers) and embryonal carcinoma components, often diagnosed based on the presence of dedifferentiated cellular elements indicating immature tissue. (Source content)

• Benign vs Malignant Ovarian Tumors: Benign tumors, such as Brenner tumor, are non-invasive and well-differentiated, whereas malignant tumors, including immature teratomas, show dedifferentiation, cellular atypia, and invasive growth. Immature teratomas are diagnosed based on the presence of dedifferentiated cellular elements, indicating immaturity. (Source content)

• Immature Teratoma: A malignant germ cell tumor distinguished histologically by the presence of immature, dedifferentiated tissues, often neuroectodermal, requiring careful histopathological grading for prognosis. (Source content)

• Non-ovarian Tumors Rarely Found in Ovary: Tumors such as endodermal sinus tumor (yolk sac tumor) are primarily extragonadal but can rarely originate in the ovary, exhibiting aggressive behavior and characteristic Schiller-Duval bodies. (Source content)

📝 Essential Points

• Malignant ovarian germ cell tumors include dysgerminoma, embryonal carcinoma, and teratocarcinoma, each with distinct histological features and prognostic implications. Dysgerminomas are the most common malignant germ cell tumor in young women, with a good prognosis when detected early. Embryonal carcinomas are highly aggressive, often presenting with elevated serum alpha-fetoprotein (AFP) or beta-hCG. Teratocarcinomas contain both mature and immature elements, with the immature components indicating malignancy, diagnosed based on dedifferentiated cellular elements. (Source content)

• Benign ovarian tumors like Brenner tumors are composed of transitional epithelium and are usually asymptomatic, whereas immature teratomas are malignant and require prompt treatment. The diagnosis of immature teratomas depends on identifying dedifferentiated cellular elements, which determine grading and prognosis. (Source content)

• Non-ovarian tumors such as endodermal sinus tumors, although rare, can occur in the ovary and are characterized by their aggressive nature and specific histological features like Schiller-Duval bodies. These tumors often produce AFP and respond well to chemotherapy. (Source content)

💡 Key Takeaway

Malignant ovarian germ cell tumors, including dysgerminoma, embryonal carcinoma, and immature teratoma, are distinguished by their histological features and cellular differentiation status, with immature teratomas diagnosed based on the presence of dedifferentiated elements, while non-ovarian tumors like endodermal sinus tumors are rare but significant due to their aggressive behavior.

📖 6. Renal Pathologies

🔑 Key Concepts & Definitions

Diabetic Nephropathy: A progressive kidney disease caused by long-standing diabetes mellitus, characterized by glomerular basement membrane thickening, mesangial expansion, and nodular glomerulosclerosis ("Kimmelstiel-Wilson nodules") as described by Kimmelstiel and Wilson (1936). It leads to proteinuria and eventual renal failure.

Renal Amyloidosis: A condition marked by extracellular deposition of amyloid proteins within the kidney, primarily affecting the glomeruli, tubules, and vasculature. Pathologically, amyloid appears as amorphous, eosinophilic deposits that stain with Congo red and show apple-green birefringence under polarized light (Glenner and Glenner, 1972).

Von Hippel-Lindau Disease: A hereditary disorder caused by mutations in the VHL gene, predisposing individuals to multiple tumors, including clear cell renal carcinoma. The disease involves abnormal vascular proliferation and cyst formation in the kidneys, with a significant risk of developing renal cell carcinoma (VHL, 1926).

Causes of Chronic Neuropathy (excluding tumors and infections): Includes metabolic, toxic, and hereditary factors such as diabetes mellitus, alcoholism, vitamin deficiencies (e.g., B12), and inherited conditions like Charcot-Marie-Tooth disease. These causes lead to distal, symmetric sensorimotor neuropathy with nerve fiber degeneration (Dyck and Thomas, 1994).

Non-neoplastic Pituitary Conditions (e.g., Rathke's Cleft Cysts): Rathke's cleft cysts are benign, sellar or suprasellar cystic lesions originating from remnants of Rathke's pouch. They are lined by ciliated epithelium and may cause pituitary dysfunction or mass effects but are non-neoplastic (Sano et al., 2000).

📝 Essential Points

• Diabetic nephropathy is the leading cause of end-stage renal disease in diabetics, with hallmark features including thickening of the glomerular basement membrane and mesangial expansion, progressing to nodular sclerosis (Kimmelstiel and Wilson, 1936).
• Renal amyloidosis involves amyloid deposits that disrupt normal kidney architecture, often leading to proteinuria and renal failure. Diagnosis relies on Congo red staining and electron microscopy revealing fibrillar deposits.
• Von Hippel-Lindau disease significantly increases the risk of renal cell carcinoma, especially the clear cell subtype, due to VHL gene mutations affecting hypoxia-inducible factors and promoting angiogenesis.
• Chronic neuropathy causes are diverse; metabolic and hereditary factors are predominant. Diabetic neuropathy is the most common, characterized by distal sensory loss and motor weakness.
• Rathke's cleft cysts are incidental findings or cause symptoms via mass effect. They are benign, lined by ciliated epithelium, and distinguished from neoplastic lesions by histology.

💡 Key Takeaway

Renal pathologies not classified as glomerulonephritis, such as diabetic nephropathy and amyloidosis, involve structural alterations and deposits that impair kidney function, while hereditary syndromes like Von Hippel-Lindau significantly increase renal carcinoma risk. Non-neoplastic pituitary lesions like Rathke's cleft cysts are benign, developmental anomalies with potential clinical implications.

📖 7. Neoplastic Lesions

🔑 Key Concepts & Definitions

• Synovial Sarcoma (characterized by biphasic pattern and t(X;18) translocation): A malignant soft tissue tumor typically affecting young adults, exhibiting both epithelial and spindle cell components. The hallmark genetic feature is the translocation t(X;18)(p11.2;q11.2), resulting in the SYT-SSX fusion gene, as described by Mertens (2000).
• Phyllodes Tumor of the Breast (with borderline and malignant forms): A fibroepithelial neoplasm of the breast characterized by a leaf-like architecture. Its classification into benign, borderline, and malignant depends on stromal cellularity, atypia, mitotic activity, and margins, as outlined by Lakhani (2012).
• Medulloblastoma (features including Homer-Wright rosettes and cerebellar origin): A highly malignant primary brain tumor originating in the cerebellum, common in children. Histologically, it displays Homer-Wright rosettes, indicating neuroblastic differentiation, as described by Gajjar (2004).
• Melanocytic Lesions (like Spitz nevus and Reed nevus): Benign melanocytic nevi with melanoma-like features. Spitz nevus shows epithelioid and spindle cells with symmetry, while Reed nevus is a variant with heavily pigmented, epithelioid cells, both mimicking melanoma but benign, as per Cohen (1994).
• Cutaneous Squamous Cell Carcinoma Variants (keratinizing, verrucous): Malignant epithelial tumors of the skin, with variants such as keratinizing (with keratin pearls) and verrucous (warty, slow-growing). Verrucous carcinoma is a low-grade, locally invasive form with minimal metastasis, described by Ackerman (1989).

📝 Essential Points

• Synovial sarcoma's biphasic pattern involves both epithelial and spindle cell components, with the t(X;18) translocation being pathognomonic (Mertens, 2000).
• Phyllodes tumors are classified based on stromal features; borderline and malignant forms show increased stromal cellularity, atypia, and mitotic figures, influencing treatment and prognosis (Lakhani, 2012).
• Medulloblastomas originate in the cerebellum, often presenting with Homer-Wright rosettes, and are classified as WHO grade IV due to their high malignancy and tendency for cerebrospinal dissemination (Gajjar, 2004).
• Melanocytic nevi like Spitz and Reed nevus can resemble melanoma histologically but are benign; distinguishing features include symmetry, maturation, and lack of atypia (Cohen, 1994).
• Variants of cutaneous squamous cell carcinoma differ in growth pattern and aggressiveness; verrucous carcinoma is notable for its exophytic, warty appearance with low metastatic potential (Ackerman, 1989).

💡 Key Takeaway

Neoplastic lesions such as synovial sarcoma, Phyllodes tumors, medulloblastoma, and melanocytic nevi display distinct histological and genetic features that are crucial for accurate diagnosis, prognosis, and management, with specific translocations and morphological patterns serving as diagnostic hallmarks.

📖 8. Histological Features

🔑 Key Concepts & Definitions

• Carcinoma Basocellular Classic (see source content): Characterized histologically by nests of basaloid cells with peripheral palisading, presence of mitoses, and clefts (artificial spaces) between tumor nests and surrounding stroma, giving a "mucinous" appearance (Author Unknown). Mitoses are usually scarce but can be present, indicating proliferative activity.

• Microscopic effects of HPV infection on epithelial cells: HPV induces characteristic cytopathic changes including perinuclear halo (clear zone around nuclei due to cytoplasmic vacuolization) and nuclear atypia (abnormal nuclear size, shape, and chromatin pattern), often seen in condylomas and intraepithelial neoplasia (Author Unknown).

• Picnosis: Defined as nuclear shrinkage accompanied by hyperchromasia (increased nuclear staining intensity), representing a degenerative nuclear change often seen in apoptotic or necrotic cells (Author Unknown).

• Mitosis count criteria for meningioma grading: Mitoses are counted in 10 high-power fields (HPF). A grade I meningioma has fewer than 4 mitoses per 10 HPF, while grade II (atypical) shows 4-19 mitoses, and grade III (anaplastic) exhibits ≥20 mitoses per 10 HPF (Author Unknown).

• Microscopic variants of endometrial adenocarcinoma: Includes serous-papillary, characterized by papillary structures with high-grade nuclear atypia, and villoglandular, featuring papillary projections with well-differentiated glandular epithelium, both showing distinct architectural and cytological features (Author Unknown).

📝 Essential Points

• Carcinoma basocellular classic displays nests with peripheral palisading and stromal retraction clefts, with mitotic figures occasionally observed, indicating cellular proliferation (Author Unknown).

• HPV infection causes epithelial cytopathic effects such as perinuclear halo and nuclear atypia, which are diagnostic features in histological examination of lesions like condylomas and intraepithelial neoplasia (Author Unknown).

• Picnosis is a nuclear degenerative change characterized by nuclear shrinkage and hyperchromasia, often associated with apoptotic cells or necrosis, serving as a marker of cellular degeneration (Author Unknown).

• Mitosis count is crucial for grading meningiomas: fewer than 4 mitoses/10 HPF indicates grade I, 4-19 mitoses/10 HPF indicates grade II, and ≥20 mitoses/10 HPF indicates grade III, correlating with tumor aggressiveness (Author Unknown).

• Variants of endometrial adenocarcinoma such as serous-papillary and villoglandular demonstrate different architectural patterns and cytological features, important for diagnosis and prognosis (Author Unknown).

💡 Key Takeaway

Histological examination reveals specific cellular and architectural features—such as mitoses, clefts, and nuclear changes—that are essential for tumor diagnosis, grading, and understanding the effects of HPV on epithelial cells. Recognizing these features aids in accurate pathology assessment and clinical decision-making.

📖 9. Genetic Abnormalities

🔑 Key Concepts & Definitions

• t(10;18) translocation: A chromosomal abnormality involving the exchange of genetic material between chromosomes 10 and 18, leading to bcl-2 overexpression in follicular lymphoma, which inhibits apoptosis and promotes tumor survival (Authors not specified).

• t(X;18)(p11.2;q11.2) translocation: A specific chromosomal translocation characteristic of synovial sarcoma, involving the fusion of the SS18 gene on chromosome 18 with SSX genes on the X chromosome, resulting in biphasic tumor morphology (Authors not specified).

• BRCA1 and BRCA2 mutations: Germline mutations in these tumor suppressor genes significantly increase the risk of ovarian and breast cancers by impairing DNA repair mechanisms, leading to genomic instability (Authors not specified).

• t(2;5)(p23;q35) translocation: A genetic rearrangement seen in anaplastic large cell lymphoma, resulting in the fusion of the ALK gene on chromosome 2 with NPM gene on chromosome 5, leading to constitutive ALK kinase activation (Authors not specified).

• Chromosomal trisomy 18: The presence of an extra chromosome 18 in cells, which is not associated with increased risk of adult renal carcinoma but is involved in other developmental abnormalities (Authors not specified).

📝 Essential Points

• The t(10;18) translocation is a hallmark of follicular lymphoma, causing bcl-2 overexpression, which prevents apoptosis and contributes to tumor persistence (source).

• The t(X;18)(p11.2;q11.2) translocation is pathognomonic for synovial sarcoma, producing a fusion gene that drives tumorigenesis (source).

• BRCA1 and BRCA2 mutations are well-established hereditary risk factors for ovarian and breast cancers, with mutations impairing homologous recombination DNA repair pathways (source).

• The t(2;5)(p23;q35) translocation results in the NPM-ALK fusion gene, which is oncogenic in anaplastic large cell lymphoma, leading to abnormal kinase activity (source).

• Trisomy 18 is a chromosomal abnormality associated with Edwards syndrome but has no proven link to increased risk of adult renal carcinoma (source).

💡 Key Takeaway

Genetic abnormalities such as specific translocations and gene mutations play crucial roles in the pathogenesis and diagnosis of various cancers, with distinct translocations like t(10;18) and t(X;18) serving as diagnostic markers for lymphoma and sarcoma, respectively, while BRCA mutations significantly elevate ovarian and breast cancer risks.

📖 10. Tumor Staging

🔑 Key Concepts & Definitions

• Tumor staging (AJCC/UICC) (American Joint Committee on Cancer, 2017): A systematic classification of cancer extent based on tumor size, invasion, lymph node involvement, and metastasis, guiding prognosis and treatment. For example, endometrial adenocarcinoma pT3b N1 indicates deep invasion and lymph node metastasis.

• pT3b N1 in endometrial adenocarcinoma: A staging notation where "pT3b" signifies tumor invasion beyond the uterus into the serosa or adnexa, and "N1" indicates regional lymph node metastasis, crucial for prognosis and therapy planning.

• Staging importance in chemotherapy decision making (see section 3): Accurate tumor staging informs the choice of chemotherapeutic regimens, with advanced stages often requiring more aggressive systemic therapy.

• Metastatic patterns of breast cancer (see section 4): Breast cancer commonly metastasizes to the brain, bones, liver, and lungs, with specific patterns influencing staging, prognosis, and treatment strategies.

• Clinical staging criteria for cervical carcinoma advanced disease: Includes tumor size >4 cm, parametrial invasion, and involvement of adjacent organs, which categorize the disease as FIGO stage IIIB or higher, impacting treatment options.

📝 Essential Points

• Tumor staging integrates tumor size, invasion depth, lymph node status, and distant metastasis, providing a prognosis framework and guiding treatment decisions (AJCC 2017). For example, endometrial adenocarcinoma pT3b N1 indicates advanced local invasion and nodal spread, often requiring combined surgery and adjuvant therapy.

• The decision to administer chemotherapy depends heavily on staging; early-stage tumors may be managed surgically, while advanced stages necessitate systemic treatment (staging importance in chemotherapy decision making for cancer).

• Breast cancer's metastatic pattern to the brain and other organs is a key consideration in staging and prognosis, influencing surveillance and therapeutic approaches.

• In cervical carcinoma, clinical staging considers tumor size, parametrial involvement, and extension to adjacent structures, which are critical for selecting appropriate treatment modalities (clinical staging criteria for cervical carcinoma advanced disease).

💡 Key Takeaway

Tumor staging is a vital process that combines clinical and pathological data to determine cancer extent, directly influencing prognosis, treatment planning, and survival outcomes. Accurate staging ensures optimal, personalized patient management.

📊 Synthesis Tables

⚠️ Common Pitfalls & Confusions

1. Confusing immune deposits in membranous GN (subepithelial) with those in MPGN (subendothelial/intramembranous).
2. Mistaking dense deposits in MPGN Type II as immune complexes; they are primarily complement deposits.
3. Overlooking the significance of cyclin D1 overexpression in mantle cell lymphoma, leading to misclassification.
4. Misidentifying ALK fusion as a feature of all T-cell lymphomas; it is specific for ALCL.
5. Assuming all glomerulonephritides are primary; secondary causes like amyloidosis or systemic diseases must be considered.
6. Confusing tumor markers: Bcl-2 (follicular lymphoma) vs Bcl-6 (diffuse large B-cell lymphoma).
7. Misinterpreting reactive lymph node features as lymphoma without considering clinical context.

✅ Exam Checklist

• Know the electron-dense thickening of basement membrane in membranous glomerulonephritis and the formation of spikes, as described by authors like N. K. et al.
• Understand the classification of MPGN into Types I and II, including dense deposit disease and complement pathway involvement.
• Recognize IgA nephropathy's mesangial IgA deposits and its clinical presentation following mucosal infections.
• Differentiate primary glomerulopathies from secondary causes such as amyloidosis and Goodpasture syndrome.
• Recall the significance of immune complex deposits location (subepithelial, subendothelial, intramembranous) in glomerulonephritis.
• Know that Bcl-2 overexpression results from t(10;18) in follicular lymphoma and its role in apoptosis inhibition.
• Understand the immunophenotype of Sezary syndrome (CD2+, CD3+, CD4+, CD7-) and its diagnostic importance.
• Recognize HER2/neu amplification and hormone receptor status (ER, PR) as prognostic markers in breast cancer.
• Know HPV types associated with specific epithelial lesions, especially HPV-12 with verruca.
• Recall the t(2;5)(p23;q35) translocation leading to ALK fusion in ALCL and its prognostic implications.
• Identify mantle cell lymphoma by its CD20+, CD5+, cyclin D1+ profile and t(11;14) translocation.
• Recognize ALCL's features, including ALK positivity and t(2;5) translocation, as diagnostic markers.
• Differentiate reactive lymph nodes with hyperplastic germinal centers and granulomas from malignant lymphomas.